Viewing Study NCT06503094


Ignite Creation Date: 2025-12-25 @ 1:35 AM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT06503094
Status: RECRUITING
Last Update Posted: 2024-07-16
First Post: 2024-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Lymphoblastic Leukemia/Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR-T View
None dual-target View
None Relapsed / Refractory B Cell Hematological Tumors View